Every one of those 1 sits in a single category, medical-devices. Mesa Laboratories is most often covered alongside Biopharmaceutical Development, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Mesa Laboratories appears in 1 tracked Healthcare story from August 17, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Mesa Laboratories
Every one of those 1 sits in a single category, medical-devices. Mesa Laboratories is most often covered alongside Biopharmaceutical Development, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Mesa Laboratories appears in 1 tracked Healthcare story from August 17, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 13 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Mesa Laboratories. Shared-story counts are live from our verified record — not editorial picks.
Mesa Laboratories' Q1 FY2027 shows margin expansion to 64.9% and 19.5% adjusted operating income growth, but its Sterilization and Disinfection Control segment declined 3.6% organically due to fulfillment and delivery execution issues. Clinical genomics was flat as China fell 7%, underscoring uneven healthcare demand.